175 related articles for article (PubMed ID: 28681333)
21. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
22. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
[TBL] [Abstract][Full Text] [Related]
23. Childhood asthma: improved efficacy of pressurized terbutaline aerosol by use of a 750-ml spacer.
Hidinger KG; Kjellman NI
Respiration; 1984; 45(2):157-60. PubMed ID: 6374804
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
Learoyd TP; Burrows JL; French E; Seville PC
Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
[TBL] [Abstract][Full Text] [Related]
25. [Continuous nebulization with terbutaline sulfate under tent inhalation. Evaluation of the efficacy in children 2 to 5 years of age in asthmatic crises].
Lotufo JP; Ejzenberg B; Vieira S; Mukai L; Macedo H; Yamashita C; Ventura G; Baldacci ER; Okay Y
Rev Mal Respir; 1998 Jun; 15(3):255-61. PubMed ID: 9677633
[TBL] [Abstract][Full Text] [Related]
26. Liposomal form of erlotinib for local inhalation administration and efficiency of its transport to the lungs.
Szabová J; Mišík O; Fučík J; Mrázová K; Mravcová L; Elcner J; Lízal F; Krzyžánek V; Mravec F
Int J Pharm; 2023 Mar; 634():122695. PubMed ID: 36758881
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
28. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
Liu C; Shi J; Dai Q; Yin X; Zhang X; Zheng A
Drug Dev Ind Pharm; 2015 Feb; 41(2):272-8. PubMed ID: 24252110
[TBL] [Abstract][Full Text] [Related]
29. Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator.
Biddiscombe MF; Barnes PJ; Usmani OS
J Aerosol Med; 2006; 19(3):245-53. PubMed ID: 17034300
[TBL] [Abstract][Full Text] [Related]
30. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
Cipolla D; Wu H; Gonda I; Chan HK
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
[TBL] [Abstract][Full Text] [Related]
31. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
[TBL] [Abstract][Full Text] [Related]
32. Pirfenidone-loaded liposomes for lung targeting: preparation and in vitro/in vivo evaluation.
Meng H; Xu Y
Drug Des Devel Ther; 2015; 9():3369-76. PubMed ID: 26185416
[TBL] [Abstract][Full Text] [Related]
33. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
Thi TH; Danède F; Descamps M; Flament MP
Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
[TBL] [Abstract][Full Text] [Related]
34. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
Waldrep JC; Berlinski A; Dhand R
J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.
Saari M; Vidgren MT; Koskinen MO; Turjanmaa VM; Nieminen MM
Int J Pharm; 1999 Apr; 181(1):1-9. PubMed ID: 10370197
[TBL] [Abstract][Full Text] [Related]
37. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
38. Innovative pulmonary targeting of terbutaline sulfate-laded novasomes for non-invasive tackling of asthma: statistical optimization and comparative
Elkomy MH; El Menshawe SF; Kharshoum RM; Abdeltwab AM; Hussein RRS; Hamad DS; Alsalahat I; Aboud HM
Drug Deliv; 2022 Dec; 29(1):2058-2071. PubMed ID: 35801404
[TBL] [Abstract][Full Text] [Related]
39. Aerosol characterisation of nebulised liposomes co-loaded with erlotinib and genistein using an abbreviated cascade impactor method.
Nimmano N; Somavarapu S; Taylor KMG
Int J Pharm; 2018 May; 542(1-2):8-17. PubMed ID: 29496458
[TBL] [Abstract][Full Text] [Related]
40. The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.
Petersen AH; Korsatko S; Köhler G; Wutte A; Olschewski H; Sparre T; Råstam J; Wollmer P; Pieber TR
Br J Clin Pharmacol; 2010 Mar; 69(3):271-8. PubMed ID: 20233198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
